Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 5

Ultrasonographic assessment of the cutaneous changes induced by topical flavonoid therapy

Authors Crisan D, Crisan M, Moldovan ML, Lupsor, Badea R

Received 4 September 2011

Accepted for publication 17 October 2011

Published 10 January 2012 Volume 2012:5 Pages 7—13


Review by Single anonymous peer review

Peer reviewer comments 2

Diana Crisan1, Maria Crisan2, Mirela Moldovan3, Monica Lupsor4, Radu Badea4
Student, Faculty of Medicine, 2Department of Histology, 3Department of Dermopharmacy and Cosmetics, 4Department of Ultrasonography, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, Romania

Abstract: Ultrasonography allows the quantification of dermal density and echogenicity changes during the physiological senescence process. Some active ingredients are able to slow down the tissular degeneration and disorganization process. The purpose of this study was to assess the cutaneous changes induced by the topical use of products containing Viniferol® as active ingredient, using high-frequency ultrasound. The study was performed over 12 weeks and included 80 healthy Caucasian female subjects, aged 22–75 years, divided into two groups: the study group and the control group. The product was applied according to a predetermined protocol. The measurements performed for each subject were: the thickness of the epidermis and dermis (mm), the number of low, medium, and high echogenic pixels, and the number of low echogenic pixels in the upper dermis/number of low echogenic pixels in the lower dermis. All the parameters showed a significant improvement. Ultrasound measurements showed an increase of the mean thickness of the epidermis (P < 0.0001) and dermis (P < 0.0001) following the application of the Viniferol product as compared to the control group. The changes in the dermal echogenicity confirm the efficacy and direct action of Viniferol upon the cutaneous fibroblasts. No side effects related to the treatment were recorded. The study proves the efficacy of this active ingredient in the cutaneous senescence process as well, as the fact that anti-aging prophylaxis should be initiated in the 20–40 year critical age group. This interval involves specific changes in dermal echogenicity that quantify intense molecular, biochemical and structural changes, being thus mostly and highly responsive to the anti-aging therapy.

Keywords: ultrasonography, flavonoid therapy, cutaneous changes, anti-aging therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]